“The implementation of C-RAD’s cutting-edge technology is great news for the cancer patients in Berlin. C-RAD is excited to commence the cooperation with the team at DTZ Berlin.” says Tim Thurn, CEO and President of C-RAD AB, “Surface tracking is on its way to become standard of care within radiation therapy for multiple treatment indication. The Catalyst+ system combines C-RAD patented and proven technology with an advanced software platform designed to demonstrate a new performance-level in optical surface tracking.”
The order amounts to a total just above 11 MSEK and includes the delivery of the systems and a service contract. Delivery and installation are expected to commence in fall of this year. The last system is expected to be installed in 2021.
About DTZ Berlin
DTZ Berlin is one of Germany’s largest licensed specialist oncology facilities, founded by Prof. Wolfgang Mohnike, with an experience of 30 years in diagnostic and treatment. The facility comprises two locations in Berlin and four specialist areas, which are closely integrated and can draw on state-of-the art equipment. These include two diagnostic centers for nuclear medicine and radiology and two treatment centers, one for interventional oncology and radionuclide therapy, the other for radiotherapy.
These four specialist departments are supported by their own in-house radiochemistry facilities and Germany’s only outpatient cyclotron. Along with medical expertise, DTZ Berlin is also equipped with state-of-the-art, high-performance diagnostic and therapeutic equipment – from innovative hybrid imagery to high-precision radiotherapy machinery – all connected using specialist medical software.
About C-RAD
C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm.
Back to HCB News
